23andMe Funding
$2.5B
1111 rounds
23andMe is active in the following markets / industries: biotechnology and search. The company has secured funding across 11 rounds and is valued at $2.5B. Their most recent funding was raised on July 25, 2018.
Funding Rounds
U
$300000000UnknownJul 2018
F
$250000000
E
$115000000
U
$79100000
U
$65000000U
$1400000D
$57900000C
$9000000C
$22000000
B
$12600000
A
$9000000
Investors of 23andMe
Glaxosmithkline
Develops/manufactures pharmaceuticals, vaccines, & healthcare products
Rounds
U
We help the daring build legendary companies
Rounds
F
Patrick is Managing General Partner of Xfund. He was co-head of NEA’s Consumer and Seed-stage investing practices.
Stephens Investment Management
Founder @Google
MPM Capital
Illumina
Develops tools for DNA, RNA, and protein analysis for disease research
Xfund
We support lateral thinkers
National Institutes of Health
